Timeline: Caraco v Novo Nordisk
Below, Managing IP provides a timeline of the battle between generic drug manufacturer Caraco Pharmaceutical Laboratories and Prandin manufacturer Novo Nordisk, which was argued at the Supreme Court today
The case is the first of two patent cases the High Court will hear this week. Caraco involves a dispute over the extent to which a brand drug manufacturer is required to stipulate covered uses in a Federal Drug Administration filing....
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.